Article Text

PDF
Treatment of neonatal seizures
  1. Janet Rennie1,
  2. Geraldine Boylan2
  1. 1University College London Hospitals NHS Foundation Trust, London, UK
  2. 2Department of Paediatrics & Child Health, University College Cork, Cork, Ireland
  1. Correspondence to:
    Dr Rennie
    Elizabeth Garrett Anderson Obstetric Hospital, Huntley Street, London WC1E 6DH, UK; janetmrennie{at}btinternet.com

Abstract

Newborn babies with unusual movements thought to represent seizures are usually given a loading dose of phenobarbitone without electroencephalography being performed. Antiepileptic drugs (AEDs) are then continued, with the outcome determined by clinical observation alone. AED treatment, often involving multiple drugs for long periods, is undesirable at a time when the brain is developing rapidly and likely to be especially vulnerable to any toxic effects. Despite considerable advances in the pharmacology of AEDs, continuous EEG monitoring using compact digital systems with simultaneous videorecording allowing off-line analysis, automated seizure detection, neuroimaging, and basic science research on cellular mechanisms of brain injury, treatment of such babies has progressed little. A change in practice is long overdue to allow affected babies to benefit from the advances made.

  • AED, antiepileptic drug
  • EEG, electroencephalography
  • GABA, γ-aminobutyric acid
  • electroencephalography (EEG)
  • antiepileptic drugs
  • cerebral function monitoring
  • neurology
  • seizures

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.